GENE ONLINE|News &
Opinion
Blog

2025-11-27|

Multicenter Trial OCEAN-OT to Study Occupational Therapy’s Role in Improving Quality of Life for Older Cancer Patients

by GOAI
Share To

A new multicenter, randomized controlled trial, known as OCEAN-OT, will investigate the impact of occupational therapy on the quality of life for older adults diagnosed with cancer. The study aims to assess how occupational therapy interventions influence key aspects such as physical functioning, emotional well-being, and overall daily living activities in this patient population. Researchers designed the trial to provide pragmatic insights into whether these therapies can improve outcomes for individuals facing both aging-related challenges and cancer treatment.

The protocol for the study has been published in *BMC Geriatrics*. The research will involve multiple centers and focus on older adults who are undergoing or have completed cancer treatment. By employing a randomized controlled methodology, the study seeks to generate robust data on how occupational therapy may address specific needs related to mobility, independence, and mental health among participants. This initiative represents an effort to better understand supportive care strategies that could enhance the lives of older cancer patients.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 27, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Takeda R&D President Andy Plump and GV Managing Partner Krishna Yeshwant Announce Retirements
2026-09-12
Shine Spect USA Updates Clinical and Safety Guidelines for Xenon Xe-133 Gas
2026-09-11
Amorepacific Updates Hera Black Cushion Ingredient Disclosures for Ten Foundation Shades
2026-09-11
AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring
2026-09-11
Record Investor Attendance at NLS Days 2026 Drives Nordic Life Science Dealmaking
2026-09-11
Disc Medicine and Silence Therapeutics Develop Polycythemia Vera Treatments to Compete With Takeda and Protagonist
2026-09-11
Leucine Supplementation Linked to Reduced Lymphoid Malignancy Growth and Improved Survival in Study
2026-09-11
Scroll to Top